Thursday 16 April 2026

One To Watch

Atopia Therapeutics

A Swiss biotech developing novel microbiome-based for allergic diseases.

Company Overview

Want to Update your Company's Profile?


Latest Atopia Therapeutics News

Atopia Therapeutics names Gregoire Chevalier as CEO
7 May 2024
More Atopia Therapeutics news >


Today's issue

Yvonne McGrath named CSO at Enodia
Biotechnology
Yvonne McGrath named CSO at Enodia
15 April 2026
Biotechnology
Beeline Medicines debuts with BMS-derived pipeline
15 April 2026
Pharmaceutical
J&J beats estimates and raises forecast
15 April 2026
Pharmaceutical
Neffy approved as the first needle-free anaphylaxis treatment in Canada
15 April 2026
Pharmaceutical
FDA demands trial safety data on Foundayo after approval
15 April 2026
Pharmaceutical
Rubicon enters Indian CNS formulations market with buy of Arinna Lifesciences
15 April 2026
Biotechnology
Obsidian and Galera reveal reverse merger plan
15 April 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze